• Pitt
  • Health Sciences
  • UPMC
Regenerative Medicine at the McGowan InstituteRegenerative Medicine at the McGowan InstituteRegenerative Medicine at the McGowan InstituteRegenerative Medicine at the McGowan Institute
  • Home
  • Our People
    • Faculty/Staff Bios
    • Core Faculty Publications
    • Administrative Resources
  • Our Technologies
  • About Us
    • Welcome
    • Video
    • Mission Statement
    • What Is Regenerative Medicine?
    • Executive Committee
    • Contact Us
    • Clinical Site
  • Our Research
    • Focus Areas
      • Tissue Engineering and Biomaterials
      • Cellular Therapies
      • Medical Devices and Artificial Organs
      • Clinical Translation
    • Matrix
    • Centers
    • Laboratories
    • Clinical Trials
    • Initiatives
  • Media
    • Current News
    • News Archive
    • Video
    • Podcasts
    • Newsletter
    • Grant of the Month
    • Publication of the Month
    • Media Contact
    • Video Links
  • Professional Development
    • Seminar Series
    • Special Events
    • Student Interest Groups
    • CATER
    • Post-Doctoral Opportunities
    • Career Opportunities
    • Wiegand Summer Internship
    • Admissions
    • Summer School
    • 2021 Scientific Retreat

Medical Devices

Home Archive by category "Medical Devices"

ALung Announces a Key Milestone Achievement in Its VENT-AVOID Pivotal Trial

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | March 25, 2021

ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced the recent achievement of a significant milestone – enrollment of 100 patients in its U.S. based VENT-AVOID pivotal trial. Read More

Pitt-McGowan Institute Center for Preclinical Studies Supports Total Artificial Heart Study

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | February 10, 2021
carmat tah

Carmat, a developer of an artificial heart which offers a bridge to transplant in patients with end-stage biventricular heart failure, recently reported its total artificial heart (TAH) received the European CE mark. The artificial heart provides an alternative for individuals for whom maximal medical therapy and left ventricular assist device are insufficient or contraindicated. It is designed for patients expected to receive a heart transplant within 180 days. Read More

Breathing Easier with a Better Tracheal Stent

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | January 21, 2021
drs c w k and t

Pediatric laryngotracheal stenosis (LTS), a narrowing of the airway in children, is a complex medical condition. While it can be something a child is born with or caused by injury, the condition can result in a life-threatening emergency if untreated.  Treatment, however, is challenging. Depending on the severity, doctors will use a combination of endoscopic techniques, surgical repair, tracheostomy, or deployment of stents to hold the airway open and enable breathing. Read More

Dr. Youngjae Chun Receives Second-Year Research Funding from The Children’s Heart Foundation

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | January 13, 2021
ychun

McGowan Institute for Regenerative Medicine affiliated faculty member Youngjae Chun, PhD, associate professor of industrial engineering and bioengineering at the University of Pittsburgh Swanson School of Engineering, will receive second-year research funding as part of more than $735,000 from The Children’s Heart Foundation, the nation’s leading organization dedicated to funding congenital heart defect (CHD) research. Read More

Synthetic Biology and Machine Learning Speed the Creation of Lab-Grown Livers

By The McGowan Institute For Regenerative Medicine | Computations and Modeling, Current News, Medical Devices | December 8, 2020
drs e and k

Researchers at the University of Pittsburgh School of Medicine have combined synthetic biology with a machine-learning algorithm to create human liver organoids with blood- and bile-handling systems. When implanted into mice with failing livers, the lab-grown replacement livers extended life. Read More

Podcast: What’s New in Military Medicine with Dr. Ron Poropatich

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | December 2, 2020
cmmr partnerships

At the University of Pittsburgh, the Center for Military Medicine Research (CMMR) recognizes the urgency for innovating to meet the demands of an increasingly complex security environment. Researchers have focused current and future efforts in the areas of trauma, emergency, and critical care. In doing so, the multi-disciplinary and multi-organizational-led team aims to significantly enhance the trauma care of the warfighter with direct relevance to civilian trauma care while also spurring the economic growth in the Pittsburgh region. Read More

Dr. Catalin Toma Reports Interim FLASH Registry Results on FlowTriever System

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | November 4, 2020
TomaC

The FlowTriever percutaneous mechanical thrombectomy system (Inari Medical) is safe and provides immediate benefits to patients with acute pulmonary embolism (PE), interim results of the real-world FLASH registry suggest.  McGowan Institute for Regenerative Medicine affiliated faculty member Catalin Toma, MD, Director of Interventional Cardiology for the Heart and Vascular Institute, Director of the Interventional Fellowship at UPMC, and an Assistant Professor of Medicine at the University of Pittsburgh School of Medicine, presented study results during TCT Connect 2020. Read More

Getting the Full Scope

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices, Neuroscience | October 28, 2020
3b kozai image

A neural interface — or brain-computer interface — is a device that uses electrical stimulation to induce changes in brain activity. Among other applications, its positive effects are being leveraged to rehabilitate neurological conditions, such as Parkinson’s disease. Read More

Monitoring Coronary Artery Disease in Real-Time

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | October 21, 2020
youngjae work

Coronary artery disease – a leading cause of death in the US – narrows or blocks arteries that carry a vital supply of blood, oxygen, and nutrients to the heart. A stent can be inserted to widen the artery, but these devices must be closely monitored to ensure that they do not re-narrow, a common complication called restenosis. Read More

Team Receives $1M NSF Award to Create At-Home Glaucoma Monitoring Device

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices, Vision | October 7, 2020
drs s and c

Diabetic patients monitor their blood glucose throughout the day, watching for peaks and valleys. Just taking a sample once during a visit to the doctor’s office would not give a clear picture of whether the patient’s diabetes is under control. The same is true of glaucoma patients, whose intraocular pressure (IOP), or pressure within the eye, is too high. Read More

HERL Receives Patent for Computer Pointing Device

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | October 7, 2020
cooper

University of Pittsburgh’s Human Engineering Research Laboratories (HERL) recently announced its latest patent to help improve mobility for people who use prosthetics. Read More

Tailor-Made Polymers Easier to Obtain

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | September 30, 2020
Matyjaszewski2

Polymer particles of any architecture, e.g. combs, stars, rings, have been produced for years thanks to the groundbreaking ATRP method discovered by Krzysztof Matyjaszewski, PhD, the J.C. Warner Professor of Natural Sciences at Carnegie Mellon University and affiliated faculty member of the McGowan Institute for Regenerative Medicine. Now scientists show how to carry out such reactions even more easily – in the presence of oxygen, in homelike conditions. Read More

Predictive Placentas: Using Artificial Intelligence to Protect Mothers’ Future Pregnancies

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | September 23, 2020
cmu placenta

After a baby is born, doctors sometimes examine the placenta—the organ that links the mother to the baby—for features that indicate health risks in any future pregnancies. Unfortunately, this is a time-consuming process that must be performed by a specialist, so most placentas go unexamined after the birth. A team of researchers from Carnegie Mellon University (CMU) and the University of Pittsburgh Medical Center (UPMC)—including McGowan Institute for Regenerative Medicine affiliated faculty member Philip Leduc, PhD, William J. Brown Professor of Mechanical Engineering with appointments in Biological Sciences, Computational Biology, and Biomedical Engineering at CMU—report the development of a machine learning approach to examine placenta slides in The American Journal of Pathology, published by Elsevier, so more women can be informed of their health risks. Read More

Blood-Thinner with No Bleeding Side-Effects Is On the Horizon

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | September 2, 2020
cook

Patients who suffer from thrombosis, pulmonary embolism or stroke are usually put on drugs that help their blood flow more smoothly through their body. Occupying a large section of the drug market, anticoagulants, or “blood thinners” as they are popularly known, can keep blood clots from forming or getting bigger, and can therefore help with recovery from heart defects or prevent further complications. Read More

SBIR Grant to Address Microvascular Obstructions

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | August 19, 2020
Pacella_2013

McGowan Institute for Regenerative Medicine affiliated faculty member John Pacella, MD, Associate Professor in the School of Medicine at the University of Pittsburgh and an Interventional Cardiologist within the UPMC Heart and Vascular Institute, is partnering with Microvascular Therapeutics (MVT), a biotechnology company based in Tucson, Arizona, and a leader in microbubble technology.  MVT recently was awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health. Read More

U.S. Department of Transportation Grants $1 Million to Pitt’s New University Transportation Center

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | August 19, 2020
cooper

The U.S. Department of Transportation recently announced $4.925 million in grants to fund four new Tier 1 University Transportation Centers (UTCs) to advance research and education programs that address critical transportation challenges facing our nation.  The University of Pittsburgh was named one of the recipients of $1 million for its project entitled “Implications of Accessible Automated Vehicles and Mobility Services for People with Disabilities.” Read More

Dr. Kacey Marra Forms AxoMax Technologies to Commercialize Nerve Repair Research

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | August 12, 2020
Marra 2016

The path to impact for basic life science research can be long and filled with big gaps: in time and in resources. Read More

Project on Analyzing Cells for Future Biomedical Devices Awarded 5-Year NIH Grant

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | August 5, 2020
yuliwang

McGowan Institute for Regenerative Medicine Yu-li Wang, PhD, and his team are researching cell migration while using the technologies developed for potential applications in artificial organs and other devices. The team has been awarded a five-year research grant from the National Institute of General Medical Sciences (NIGMS), one of the National Institutes of Health, to support this work. Read More

A Remote Control for Neurons

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | July 22, 2020
cohenkarni work

The team led by researchers at Carnegie Mellon University (CMU) has created a new technology that enhances scientists’ ability to communicate with neural cells using light.  McGowan Institute for Regenerative Medicine affiliated faculty member Tzahi Cohen-Karni, PhD, CMU’s associate professor of biomedical engineering and materials science and engineering, led a team that synthesized three-dimensional fuzzy graphene on a nanowire template to create a superior material for photothermally stimulating cells. NW-templated three-dimensional (3D) fuzzy graphene (NT-3DFG) enables remote optical stimulation without the need for genetic modification and uses orders of magnitude less energy than available materials, preventing cellular stress.  This work was presented in the Proceedings of the National Academy of the Sciences. Read More

Infant Heart-Assist Device Gets New Life with $4.7M Grant

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | July 15, 2020
antaki pediaflow

The Center for Disease Control estimates that roughly 40,000 infants are born with congenital heart defects (CHDs) each year. Among that population, 25 percent are critical cases that require cardiac surgery. The waitlist for a heart transplant continues to grow; yet, the only FDA-approved life-saving device for CHD has shortcomings and is based on technology from the 1970s. Read More

Podcast: What’s Being Done for Acute Kidney Stress/Injury with Dr. John Kellum

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | June 10, 2020
kellum

Acute kidney injury is common in hospitalized patients, particularly those in intensive care units and older adults, and refers to a sudden episode of kidney failure or damage that happens within a few hours or days. It causes a build-up of waste products in the blood that can affect other organs, including the brain, heart, and lungs. Read More

Podcast: McGowan Institute-Developed Technology—Hemolung® RAS History, COVID-19 Patients, and What’s on the Horizon

By The McGowan Institute For Regenerative Medicine | CoVid-19, Current News, Medical Devices | June 3, 2020
William-Federspiel-BioE-Faculty2

A respiratory dialysis system that was developed at the McGowan Institute for Regenerative Medicine Medical Devices Lab has been used to treat 16 COVID-19 patients, in conjunction with non-invasive or mechanical ventilation.  The core technology developed at the Medical Devices Lab, was licensed to the spinout ALung Technologies, and ALung has designed and produced a clinically viable device, which is called the Hemolung® Respiratory Assist System (RAS). Read More

Using a Smartphone to Diagnose COVID-19 at Home

By The McGowan Institute For Regenerative Medicine | CoVid-19, Current News, Medical Devices | May 27, 2020
gao1

In Pennsylvania and other U.S. states, one of the keys to safely reopening society amid the COVID-19 pandemic is providing sufficient testing so that new cases of the disease do not overwhelm the public healthcare system. University of Pittsburgh professors—led by McGowan Institute for Regenerative Medicine affiliated faculty member Wei Gao, PhD—are  reimagining testing using a device that nearly every American owns — a smartphone. Read More

Carnegie Mellon, Pitt Researchers Launch Ventilator Project

By The McGowan Institute For Regenerative Medicine | CoVid-19, Current News, Medical Devices | May 20, 2020
cook1

Researchers at Carnegie Mellon University (CMU) and the University of Pittsburgh School of Medicine are developing a new, low-cost ventilator they say will address the ventilator shortage, both now and in the future, that has been made evident by the COVID-19 pandemic.  The team includes McGowan Institute for Regenerative Medicine affiliated faculty member Keith Cook, PhD, a CMU professor of biomedical engineering.  Dr. Cook, of CMU’s Biomedical Engineering Department, has expertise in advanced respiratory support, including the design and development of artificial lungs, liquid ventilation hardware and techniques, and animal models of lung disease. Read More

Potential Portable Individual Biocontainment Unit to Reduce COVID-19 Transmission

By The McGowan Institute For Regenerative Medicine | CoVid-19, Current News, Medical Devices | April 29, 2020
bio containment unit

A multidisciplinary team of researchers and clinicians, including McGowan Institute for Regenerative Medicine faculty member Peter Rubin, MD, FACS, Chair of the Department of Plastic Surgery, the UPMC Endowed Professor of Plastic Surgery, Director of UPMC Wound Healing Services, and Professor of Bioengineering at the University of Pittsburgh, is working on a low-cost negative pressure hood that can be used to protect medical staff during intubations and other situations where aerosol spray is likely from infected patients. Moreover, it can also help prevent spread in environments without a negative pressure room, such as the Emergency Department of a hospital. This apparatus is different and far advanced compared with static protection boxes which are only passive shields.  What makes this new hood most remarkable is its active airflow and HEPA filtering. Read More

FDA Grants ALung Technologies Emergency Use Approval for its Hemolung to Treat COVID-19 Patients with Respiratory Distress

By The McGowan Institute For Regenerative Medicine | CoVid-19, Current News, Medical Devices | April 29, 2020
hemolung ras

A device designed at the McGowan Institute for Regenerative Medicine could help improve outcomes as a treatment for COVID-19 when used in conjunction with non-invasive or mechanical ventilation, and it recently received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration. Health records from a New York study showed that close to 90 percent of patients who were placed on mechanical ventilation did not survive. Some intensive care units are now considering mechanical ventilation as a last resort because of the complications and side effects associated with the process, and researchers believe this device could help. Read More

Medical Devices Lab Technology May Help COVID-19 Patients

By The McGowan Institute For Regenerative Medicine | CoVid-19, Current News, Medical Devices | April 22, 2020
William-Federspiel-BioE-Faculty2

Under the direction of McGowan Institute for Regenerative Medicine faculty member William Federspiel, PhD, the William Kepler Whiteford Professor in the Department of Bioengineering at the University of Pittsburgh, the Institute’s Medical Devices Laboratory is developing clinically significant devices for the treatment of pulmonary and other cardiovascular ailments by utilizing the engineering principles of fluid flow and mass transfer. Read More

Developing a Valve for Developing Hearts

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | April 8, 2020
ychun

Approximately one in every 125 babies in the U.S. is born with a congenital heart defect (CHD), making it the country’s most common birth defect. Heart valves developed for adults have been used on infants to treat CHDs, but the large devices sometimes require open heart surgery, presenting a severe risk to infants and young children. Additionally, infants and children grow quickly, but the artificial valve does not, resulting in repeated surgeries that increase risks. Read More

DARPA Awards $22M for ‘Smart’ Device that Regenerates Muscle

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | March 11, 2020
Device

A multi-institution research team led by the University of Pittsburgh secured a $22 million grant from the Defense Advanced Research Projects Agency (DARPA) to develop a device combining artificial intelligence, bioelectronics and regenerative medicine to regrow muscle tissue, especially after combat injuries. Read More

Dr. Takashi Kozai Receives $1.6M NIH Award to Develop an Innovative Wireless Neural Device for Long-Term and Precise Stimulation

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | January 29, 2020
3b kozai light

Neural stimulation is a pioneering technology that can be used to recover function and improve the quality of life for individuals who suffer from brain injury or disease. It serves an integral role in modern neuroscience research and human neuroprosthetics, including advancements in prosthetic limbs and brain-computer interfaces. A challenge that remains with this technology is achieving long-term and precise stimulation of a specific group of neurons. Read More

Abbott Gets FDA Approval for Less-Invasive Heart Pump Implant Procedure

By The McGowan Institute For Regenerative Medicine | Cellular Therapy, Current News, Medical Devices | January 22, 2020
NEW Kormos Headshot

Abbott Laboratories, the Abbott Park, Illinois-based health care giant, has won approval from the U.S. Food and Drug Administration (FDA) for a less invasive surgical procedure that allows surgeons to implant the company’s heart pump without a patient undergoing open heart surgery. Read More

Nerve-Healing Startup Renerva Joins McGovern Incubator

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | January 22, 2020
renerva news

Renerva, a medical startup that is developing an injectable gel to speed the healing of damaged nerves and creating an off-the-shelf nerve-graft product that may spare patients life-long disability, has joined Cornell University’s McGovern Center life sciences business incubator. Read More

BioHybrid Solutions Awarded $30M Contract by the US Dept. of Defense

By The McGowan Institute For Regenerative Medicine | Current News, Medical Devices | January 8, 2020
Matyjaszewski2

McGowan Institute for Regenerative Medicine affiliated faculty member Krzysztof Matyjaszewski, PhD, is the Co-Founder and CSO of BioHybrid Solutions, LLC (BHS), a Pittsburgh-based protein engineering company, which recently received a contract worth up to $30 million from the United States Department of Defense to develop a next-generation prophylactic medical countermeasure. The project was sponsored by the U.S. Government through the Medical CBRN Defense Consortium (MCDC).  Dr. Matyjaszewski is the J.C. Warner Professor of Natural Sciences at Carnegie Mellon University. Read More

Pitt Team’s Replacement Heart Valve Could Decrease Need for Pediatric Surgeries

By The McGowan Institute For Regenerative Medicine | Medical Devices, News Archive | November 13, 2019
onevalve

Garrett Coyan, MD, sees many patients each week, from children to the elderly, to check on their replacement heart valves. Read More

Dr. Tracy Cui Leads Pitt Neuron Research in Pitt/CMU Brain Collaboration

By The McGowan Institute For Regenerative Medicine | Medical Devices, Neuroscience, News Archive | November 13, 2019
cui2016

The brain is a complex organ full of neurons that work together to help us move, feel, think, and more. A multidisciplinary group from the University of Pittsburgh (Pitt) and Carnegie Mellon University (CMU) is working to expand the amount of information researchers can receive from a neural interface device and received two grants from the National Science Foundation (NSF) for their collaborative effort. Read More

Manufacturing in Microgravity

By The McGowan Institute For Regenerative Medicine | International Space Station, Medical Devices, News Archive | November 4, 2019
11b mg discs

Magnesium and magnesium alloys have the potential to become a revolutionary material for a variety of industries because of their lightweight structure and ability to quickly biodegrade in water or inside the human body. Researchers, however, are still struggling to process this very reactive metal to eliminate defects that accelerate corrosion. Read More

Applying Structural Monitoring Technology to the Human Spine

By The McGowan Institute For Regenerative Medicine | Medical Devices, News Archive | October 21, 2019
RichDebski-a

McGowan Institute for Regenerative Medicine affiliated faculty member Richard Debski, PhD, professor of bioengineering at the University of Pittsburgh and the co-director of the Orthopedic Robotics Laboratory, is a member of a team of researchers on a project which received $400K from the NIH to design and test a miniature, implantable, and battery-free sensor to monitor spinal fusion progress after surgery. Read More

McGowan Institute’s Pediatric VAD Technology, PediaFlow, to One Day Help the Smallest of Heart Transplant Candidates

By The McGowan Institute For Regenerative Medicine | Medical Devices, News Archive, Transplantation | October 2, 2019
pediaflow

The recent Pittsburgh Post-Gazette newspaper article by Jill Daly highlights the significant challenges infants and children face if they require a heart transplant. Read More

Potential Peripheral Nerve Repair Technology Receives NSF and NIH Funding

By The McGowan Institute For Regenerative Medicine | Medical Devices, News Archive | September 25, 2019
brown

Renerva, LLC, a medical device company developing innovative technologies for peripheral nerve repair, announced recently that it has received two additional grants totaling $500,000 from the National Science Foundation (NSF) and the National Institutes of Health (NIH), rapidly accelerating development of their medical device products. Read More

3D Printing of Soft Materials: New and Complicated Variables

By The McGowan Institute For Regenerative Medicine | Medical Devices, News Archive | September 18, 2019
drs w and f

While 3D printing soft materials, such as silicone or proteins, offers many advantages, it also introduces many new and complicated variables to consider when creating a new part, per Vanesa Listek for 3D Print in her report featuring the work of McGowan Institute for Regenerative Medicine affiliated faculty member Newell Washburn, PhD, professor of biomedical engineering and chemistry at Carnegie Mellon University (CMU). The existing soft materials that can be 3D printed commercially are somewhat limited since they don’t have all the properties that researchers need to fully advance their developments and they end up working within the constraints of the current technology. Read More

1234
  • site map
  • links
  • contact
  • subscribe to our newsletter
© Copyright 2021 McGowan Institute for Regenerative Medicine
A program of the University of Pittsburgh and the University of Pittsburgh Medical Center
  • Home
  • Our People
    • Faculty/Staff Bios
    • Core Faculty Publications
    • Administrative Resources
  • Our Technologies
  • About Us
    • Welcome
    • Video
    • Mission Statement
    • What Is Regenerative Medicine?
    • Executive Committee
    • Contact Us
    • Clinical Site
  • Our Research
    • Focus Areas
      • Tissue Engineering and Biomaterials
      • Cellular Therapies
      • Medical Devices and Artificial Organs
      • Clinical Translation
    • Matrix
    • Centers
    • Laboratories
    • Clinical Trials
    • Initiatives
  • Media
    • Current News
    • News Archive
    • Video
    • Podcasts
    • Newsletter
    • Grant of the Month
    • Publication of the Month
    • Media Contact
    • Video Links
  • Professional Development
    • Seminar Series
    • Special Events
    • Student Interest Groups
    • CATER
    • Post-Doctoral Opportunities
    • Career Opportunities
    • Wiegand Summer Internship
    • Admissions
    • Summer School
    • 2021 Scientific Retreat
Regenerative Medicine at the McGowan Institute